Mark Quinn
King's College London(GB)Pfizer (United Kingdom)(GB)York Teaching Hospital NHS Foundation Trust(GB)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Insect-Plant Interactions and Control, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis(2008)784 cited
- → Presence of significant synovitis in rheumatoid arthritis patients with disease‐modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression(2006)669 cited
- → Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve‐month randomized, double‐blind, placebo‐controlled trial(2005)533 cited
- → The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review(2009)355 cited
- → Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis(2003)345 cited